Ongoing Clinical Trials

Indication
Institution
Department
Principal Investigator
Protocol Title
TMU-JIRB No. Protocol Title Indication Institution Department Principal Investigator Contact
N202310014 A Phase III, Randomised, Multicentre, Double-blind Study to Evaluate the Efficacy, Safety, and Tolerability of Zibotentan/Dapagliflozin Compared to Dapagliflozin Alone in Participants with Chronic Kidney Disease and High Proteinuria Chronic Kidney Disease TMUH Nephrology Hsi-Hsien, Chen Yin-Ju Chen
0227372181 #7606
N202305082 HERMES: Effects of ziltivekimab versus placebo on morbidity and mortality in patients with heart failure with mildly reduced or preserved ejection fraction and systemic inflammation. heart failure TMUH Cardiology Chun-Yao Huang Ning-Xin Li
0968703924
N202305049 A randomized, double-blind, placebo-controlled multicenter study to evaluate the effect of inclisiran on preventing major adverse cardiovascular events in high-risk primary prevention patients (VICTORION-1 PREVENT) major adverse cardiovascular events TMUH Cardiology Chun-Yao Huang Yin-Ju Chen
02-27372181 #7606
N202211003 A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Effect of Tirzepatide on the Reduction of Morbidity and Mortality in Adults with Obesity overweight and obesity TMUH Cardiology Chun-Yao Huang Yin-Ju Chen
02-27372181 #7607
N202306090 A Phase 3, Randomized, Double-blind, Placebo-controlled, Event-driven Study to Demonstrate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, After a Recent Acute Coronary Syndrome Coronary Syndrome TMUH Cardiology Chun-Yao Huang Wan-Zhen Li
0975550912
N202202023 A randomized double-blind, placebo-controlled, multicenter trial, assessing the impact of inclisiran on major adverse cardiovascular events in participants with established cardiovascular disease (VICTORION-2 PREVENT) Spinal Cord Injuries (SCI) TMUH Cardiology Chun-Yao Huang Yin-Ju Chen
02-27372181
#7606
N202207020 A Multicentre, Randomized, Doubleblind Study to Evaluate and Compare the Efficacy and Safety of 8- week Treatment with Azilsartan Medoxomil and Amlodipine Besylate Combined and Alone in Mild-to-moderate Essential Hypertensive Subjects High Blood Pressure/Hypertension TMUH Cardiology Chun-Yao Huang Jia-Hua Xie
0968703924
N202209050 A multi-center, randomized, double-blind, parallel-group, 20-week dose-finding study to evaluate efficacy, safety, and tolerability of XXB750 in patients with resistant hypertension High Blood Pressure/Hypertension TMUH Cardiology Chun-Yao Huang Yin-Ju Chen
02-27372181 #7606
N202311056 A Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Efficacy and Safety of Baxdrostat in Participants with Uncontrolled Hypertension on Two or More Medications including Participants with Resistant Hypertension High Blood Pressure/Hypertension TMUH Cardiology Chun-Yao Huang Jenny Chiang
0922070196
N202403014 A Phase III, Randomised, Double -Blind, Active-controlled Study to Assess the Efficacy, Safety and Tolerability of Baxdrostat in Combination with Dapagliflozin Compared with Dapagliflozin Alone on Chronic Kidney Disease (CKD) Progression in Participants with CKD and High Blood Pressure High Blood Pressure/Hypertension TMUH Cardiology Chun-Yao Huang Ning-Xin Li
0968703924
1 2 3 4 5 6 7 8 9 10 11 12 13 / 13

TOP